JYNARQUE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Oct 2024)
What this means for you
Registered since 29 May 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87632640
- Registration number
- 5482786
- Mark type
- Stylized text
- Filed
- 03 Oct 2017
- Published for opposition
- 21 Nov 2017
- Registered
- 29 May 2018
- Attorney of record
- Scott S. Havlick
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of polycystic kidney disease (PKD)
Owner
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo, JP
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo, JP
- Otsuka Pharmaceutical Co., Ltd., Chiyoda-ku, Tokyo, JP
Prosecution history
- 24 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Oct 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 May 2024 — TEAS SECTION 8 & 15 RECEIVED
- 29 May 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 May 2018 — REGISTERED-PRINCIPAL REGISTER
- 24 Apr 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Apr 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Apr 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Mar 2018 — USE AMENDMENT FILED
- 04 Apr 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Mar 2018 — TEAS STATEMENT OF USE RECEIVED
- 16 Jan 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Nov 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Nov 2017 — PUBLISHED FOR OPPOSITION